<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8106540</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6583</journal-id>
<journal-id journal-id-type="nlm-ta">Prenat Diagn</journal-id>
<journal-id journal-id-type="iso-abbrev">Prenat. Diagn.</journal-id>
<journal-title-group>
<journal-title>Prenatal diagnosis</journal-title>
</journal-title-group>
<issn pub-type="ppub">0197-3851</issn>
<issn pub-type="epub">1097-0223</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27646161</article-id>
<article-id pub-id-type="pmc">5243172</article-id>
<article-id pub-id-type="doi">10.1002/pd.4928</article-id>
<article-id pub-id-type="manuscript">NIHMS822883</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Global transcriptome dysregulation in second trimester fetuses with <italic>FMR1</italic> expansions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zwemer</surname>
<given-names>Lillian M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nolin</surname>
<given-names>Sarah L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Okamoto</surname>
<given-names>Patricia M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eisenberg</surname>
<given-names>Marcia</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wick</surname>
<given-names>Heather C.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bianchi</surname>
<given-names>Diana W.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Mother Infant Research Institute, Tufts Medical Center, Boston, MA, USA</aff>
<aff id="A2"><label>2</label>New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA</aff>
<aff id="A3"><label>3</label>Integrated Genetics/Laboratory Corporation of America® Holdings, Westborough, MA, USA</aff>
<aff id="A4"><label>4</label>Laboratory Corporation of America® Holdings, Research Triangle Park, NC, USA</aff>
<aff id="A5"><label>5</label>Department of Computer Science, Tufts University, 155 College Ave, Medford, MA 02115 USA</aff>
<author-notes>
<corresp id="cor1"><bold>Corresponding Author:</bold> Diana W. Bianchi, Tufts Medical Center, 800 Washington St. Box 394, Boston, MA 02111, 001 (617) 636-9122, <email>dbianchi@tuftsmedicalcenter.org</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P44">
<bold>Disclosures:</bold>
</p>
<p id="P45">The authors have no conflicts of interest to disclose.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>37</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>52</lpage>
<!--elocation-id from pubmed: 10.1002/pd.4928-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">We tested the hypothesis that <italic>FMR1</italic> expansions would result in global gene dysregulation as early as the second trimester of human fetal development.</p>
</sec>
<sec id="S2">
<title>Method</title>
<p id="P2">Using cell-free fetal RNA obtained from amniotic fluid supernatant and expression microarrays we compared RNA levels in samples from fetuses with premutation or full mutation allele expansions to control samples.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">We found clear signals of differential gene expression relating to a variety of cellular functions, including ubiquitination, mitochondrial function and neuronal/synaptic architecture, among others. Additionally, among the genes showing differential gene expression, we saw links to related diseases of intellectual disability and motor function. Finally, within the unique molecular phenotypes established for each mutation set, we saw clear signatures of mitochondrial dysfunction and disrupted neurological function. Patterns of differential gene expression were very different in male and female fetuses with premutation alleles.</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P4">These results support a model for which genetic misregulation during fetal development may set the stage for late clinical manifestations of <italic>FMR1</italic>-related disorders.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>